A Review of Precision Oncology Knowledgebases for Determining the Clinical Actionability of Genetic Variants

被引:20
|
作者
Li, Xuanyi [1 ]
Warner, Jeremy L. [2 ,3 ]
机构
[1] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
[2] Vanderbilt Univ, Dept Med, Nashville, TN 37235 USA
[3] Vanderbilt Univ, Dept Biomed Informat, 221 Kirkland Hall, Nashville, TN 37235 USA
来源
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2020年 / 8卷
关键词
precision oncology; knowledgebase; variant interpretation; actionability; targeted therapy; genotype-selective clinical trial; tumor genetic testing; OFF-LABEL USE; PRIVATE MUTATIONS; PHARMACOGENOMICS KNOWLEDGE; MEDICINE; GENOMICS; TRIAL; IDENTIFICATION; INFORMATION; PREVALENCE; LANDSCAPE;
D O I
10.3389/fcell.2020.00048
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The increased availability of tumor genetic testing and targeted cancer therapies contributes to the advancement of precision medicine in the field of oncology. Precision oncology knowledgebases provide a way of organizing clinically relevant genetic information in a way that is easily accessible for both oncologists and patients, facilitating the genetic-based clinical decision making. Many organizations and companies have built precision oncology knowledgebases, intended for multiple users. In general, these knowledgebases offer information on cancer-related genetic variants as well as their associated diagnostic, prognostic, and therapeutic implications, but they often differ in their information curations, designs, and user experiences. It is advisable that oncologists use multiple knowledgebases during their practice to have them complement each other. In the future, convergence toward common standards and formats is needed to ensure that the comprehensive knowledge across all sources can be unified to bring the oncology community closer to the achievement of the goal of precision oncology.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Precision Oncology: Evolving Clinical Trials across Tumor Types
    Song, I-Wen
    Vo, Henry Hiep
    Chen, Ying-Shiuan
    Baysal, Mehmet A.
    Kahle, Michael
    Johnson, Amber
    Tsimberidou, Apostolia M.
    CANCERS, 2023, 15 (07)
  • [22] Future Approaches to Precision Oncology-Based Clinical Trials
    Mittra, Arjun
    Moscow, Jeffrey A.
    CANCER JOURNAL, 2019, 25 (04) : 300 - 304
  • [23] Determining pathogenicity of genetic variants in hypertrophic cardiomyopathy: importance of periodic reassessment
    Das, Jipin K.
    Ingles, Jodie
    Bagnall, Richard D.
    Semsarian, Christopher
    GENETICS IN MEDICINE, 2014, 16 (04) : 286 - 293
  • [24] Integrating molecular profiles into clinical frameworks through the Molecular Oncology Almanac to prospectively guide precision oncology
    Reardon, Brendan
    Moore, Nathanael D.
    Moore, Nicholas S.
    Kofman, Eric
    AlDubayan, Saud H.
    Cheung, Alexander T. M.
    Conway, Jake
    Elmarakeby, Haitham
    Imamovic, Alma
    Kamran, Sophia C.
    Keenan, Tanya
    Keliher, Daniel
    Konieczkowski, David J.
    Liu, David
    Mouw, Kent W.
    Park, Jihye
    Vokes, Natalie, I
    Dietlein, Felix
    Van Allen, Eliezer M.
    NATURE CANCER, 2021, 2 (10) : 1102 - +
  • [25] Determining the Genetic Knowledge Levels of Oncology and Chemotherapy Nurses
    Kocatepe, Vildan
    Yildirim, Dilek
    Yilmaz, Metin
    CYPRUS JOURNAL OF MEDICAL SCIENCES, 2022, 7 (04): : 507 - 512
  • [26] Making Sense of Genetic Information: The Promising Evolution of Clinical Stratification and Precision Oncology Using Machine Learning
    Baptiste, Mahaly
    Moinuddeen, Sarah Shireen
    Soliz, Courtney Lace
    Ehsan, Hashimul
    Kaneko, Gen
    GENES, 2021, 12 (05)
  • [27] Urinary Proteomics for Discovery of Gastric Cancer Biomarkers to Enable Precision Clinical Oncology
    Joshi, Neha
    Bhat, Firdous
    Bellad, Anikha
    Sathe, Gajanan
    Jain, Anu
    Chavan, Sandip
    Sirdeshmukh, Ravi
    Pandey, Akhilesh
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2023, 27 (08) : 361 - 371
  • [28] Precision oncology: A new era of cancer clinical trials
    Renfro, Lindsay A.
    An, Ming-Wen
    Mandrekar, Sumithra J.
    CANCER LETTERS, 2017, 387 : 121 - 126
  • [29] Can Systems Biology Advance Clinical Precision Oncology?
    Rocca, Andrea
    Kholodenko, Boris N.
    CANCERS, 2021, 13 (24)
  • [30] Epigenomics-guided precision oncology: Chromatin variants in prostate tumor evolution
    Furlano, Kira
    Keshavarzian, Tina
    Biernath, Nadine
    Fendler, Annika
    de Santis, Maria
    Weischenfeldt, Joachim
    Lupien, Mathieu
    INTERNATIONAL JOURNAL OF CANCER, 2025,